Core Insights - The establishment of the Korea Skin Health Industry Association in Shanghai aims to provide systematic support for Korean companies entering the Chinese market and deepen Sino-Korean industrial cooperation [1] - There is a growing demand among Chinese consumers for skin health management and high-quality products, making the Chinese market highly attractive to the Korean industry [1] - The skin health industry is currently experiencing a dual benefit period from both policy and market perspectives, with Korea having advantages in skin science research and China possessing vast clinical resources and rapid technology transfer capabilities [1] Group 1 - The association will strengthen technology implementation and talent exchange between Korea and China, potentially incubating joint projects among research institutions, hospitals, and companies [5] - The association will serve as a key node for Korean companies to gain insights into the Chinese skin health market trends, policy information, and local partners [5] - The Korean cosmetics export value has been steadily increasing, with China being a major export market, although there has been significant performance differentiation among Korean beauty brands in the domestic market [5] Group 2 - The growth drivers in the domestic market have changed, leading to increased costs and risks for foreign brands operating independently [5] - The Korean government and industry are exploring organized industrial chain collaboration and market resource integration to lower the entry barriers for small and medium-sized brands in China [5] - The "Korean National Pavilion" project, supported by Korean official institutions, is set to launch in February 2026 in Hainan Free Trade Port, aiming to serve as a permanent platform for high-quality Korean beauty products to systematically enter the Chinese market [5]

Core Insights - The "2025 Skin Pharmacology and Medical Engineering Transformation Academic Conference" was co-hosted by China Pharmaceutical University and Shanghai Skin Disease Hospital, leading to the initiative for establishing the "Skin Pharmacology Professional Committee" in China [1][3] - The skin health industry in China, encompassing skin drugs, functional skincare products, and medical aesthetics, is steadily approaching a market size of one trillion yuan, but faces challenges such as a disconnect between core discipline construction and industry development needs, insufficient interdisciplinary integration, and a shortage of high-level composite talents [3][5] Group 1 - The establishment of the Skin Pharmacology Professional Committee aims to create a collaborative mechanism covering the entire chain from basic research to clinical validation, focusing on overcoming key bottlenecks in efficacy evaluation and delivery technology [3][5] - Huaxi Biological, as a core initiator, leverages its advanced positioning and core technology in aging intervention and tissue regeneration to support the committee's establishment and the development of the discipline [5][8] - The company has developed a comprehensive research and development system centered on key substances such as hyaluronic acid, proteoglycans, and collagen, forming a complete technical chain from basic research to large-scale production [5][7] Group 2 - At the conference, Huaxi Biological's director presented a report on the physiological regulation mechanisms of extracellular matrix (ECM) in skin, highlighting the synergistic effects of hyaluronic acid and sialic acid in anti-aging and repair pathways [7] - The company has made significant contributions to academic achievements and industry experience in the ECM field, advancing cutting-edge research and establishing collaborations with top international research institutions and multinational companies [7][8] - The future focus of the Skin Pharmacology Professional Committee will include innovative drug development, efficacy evaluation system construction, breakthrough skin delivery technologies, and the application of cutting-edge technologies such as skin substitute models and AI prediction models [7][8]

Core Insights - The skin health industry in China is transitioning from a phase of external variable exploitation to a focus on internal structural refinement, emphasizing the need for continuous solutions from medical treatment to home care [2] - The theme of the SIA2025 conference is "Beauty Across Borders, Professionalism Without Boundaries," highlighting the industry's consensus on cross-disciplinary collaboration [3][5] Group 1: SIA Alliance and Its Initiatives - The SIA Alliance aims to address the challenges of effective collaboration across systems and languages by establishing itself as an "industrial operating system" [5] - The SIA Think Tank has gathered 193 experts from various fields, providing a foundation for quality content and professional insights within the industry [5][6] - The SIA100 scientific evaluation system serves as a bridge between laboratories and the market, establishing unified standards for product evaluation [6] Group 2: Key Reports and Findings - The "2025 China Medical Skincare Clinical Insight Report" was released, translating complex clinical language into actionable guidelines for the industry, focusing on common skin issues [9][11] - The results of the "SIA100 Scientific Products and Technology Achievements Collection" were announced, showcasing significant improvements in the quality and scale of entries compared to 2024 [11][12] Group 3: Research and Innovation - The conference highlighted a shift from "ingredient claims" to "mechanism claims" in efficacy skincare, with research showcasing the neurobiological mechanisms of skin conditions [12][18] - The "Regenerative Medicine Frontier" report illustrated the path from basic research to industrial application, emphasizing advancements in stem cell and exosome research [18] Group 4: Industry Collaboration and Future Directions - The "Medical Research Co-Creation Forum" aims to bridge clinical needs with industry innovations, showcasing the importance of collaborative efforts in addressing unmet clinical demands [19] - The SIA2025 conference reflects a clear industry shift towards cross-disciplinary integration, with success depending on the depth and systematic nature of professional collaboration [20]